Pengfei Xu
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 8
- Oncology top 2%
- Cancer-related Molecular Pathways 8
- Cancer Immunotherapy and Biomarkers 6
- Biological Psychiatry top 5%
- Molecular Biology top 5%
- Peroxisome Proliferator-Activated Receptors 9
-
- Liver Disease Diagnosis and Treatment 10
-
- Adipose Tissue and Metabolism 9
-
- Ferroptosis and cancer prognosis 9
-
- Glioma Diagnosis and Treatment 8
- Journals
- Angewandte Chemie International Edition (1 paper)Nature Communications (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Pengfei Xu
128 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Cancer Research 722
- Oncology 1.1k
- Biological Psychiatry 82
- Molecular Biology 2.2k
- Endocrine and Autonomic Systems 206
Countries citing papers authored by Pengfei Xu
This map shows the geographic impact of Pengfei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengfei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengfei Xu more than expected).
Fields of papers citing papers by Pengfei Xu
This network shows the impact of papers produced by Pengfei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengfei Xu. The network helps show where Pengfei Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pengfei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 8 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 19 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 37 | |
| 11 | 2021 | 25 | |
| 12 | 2021 | 42 | |
| 13 | 2021 | 50 | |
| 14 | 2021 | 16 | |
| 15 | 2020 | 6 | |
| 16 | 2020 | 53 | |
| 17 | 2018 | 1 | |
| 18 | 2015 | 4 | |
| 19 | 2015 | 21 | |
| 20 | 2015 | 14 |
About Pengfei Xu
Pengfei Xu is a scholar working on Biochemistry, Genetics and Oncology, having authored 137 papers that have together received 4.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (10 papers), Adipose Tissue and Metabolism (9 papers), Ferroptosis and cancer prognosis (9 papers), Peroxisome Proliferator-Activated Receptors (9 papers), Glioma Diagnosis and Treatment (8 papers), Cancer-related Molecular Pathways (8 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Cancer Research (722 citations), Oncology (1.1k citations) and Biological Psychiatry (82 citations). Pengfei Xu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yue Xi, Yonggong Zhai, Hong Fan, Uwe Knippschild, Yuan Guo, Shijia Pan, Tingting Xue, Zhiying Huang, Jialin Wang and Joachim Bischof. Their work appears in journals such as Angewandte Chemie International Edition, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.